Literature DB >> 15492941

Acute interstitial nephritis associated with atazanavir, a new protease inhibitor.

Ursula C Brewster1, Mark A Perazella.   

Abstract

Atazanavir is a new human immunodeficiency virus 1 protease inhibitor that has a favorable side-effect profile and is available in once-daily dosing. We report the case of a young man with human immunodeficiency virus infection who developed acute renal failure after therapy with this drug. Renal biopsy showed acute interstitial nephritis. This is the first report of acute interstitial nephritis from atazanavir.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15492941

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


  25 in total

1.  Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis.

Authors:  Shyam M Parkhie; Derek M Fine; Gregory M Lucas; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

2.  Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.

Authors:  Mohamad Zaidan; François-Xavier Lescure; Isabelle Brochériou; Sarah Dettwiler; Jean-Baptiste Guiard-Schmid; Jérôme Pacanowski; Eric Rondeau; Gilles Pialoux; Pierre-Marie Girard; Pierre Ronco; Emmanuelle Plaisier
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

Review 3.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 4.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

5.  Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Authors:  Robert C Kalayjian; Bryan Lau; Rhoderick N Mechekano; Heidi M Crane; Benigno Rodriguez; Robert A Salata; Zipporah Krishnasami; James H Willig; Jeffrey N Martin; Richard D Moore; Joseph J Eron; Mari M Kitahata
Journal:  AIDS       Date:  2012-09-24       Impact factor: 4.177

6.  The renal pathological findings in Japanese HIV-infected individuals with CKD: a clinical case series from a single center.

Authors:  Masaki Hara; Kumiko Momoki; Masamitsu Ubukata; Akihito Ohta; Akiko Tonooka; Minoru Ando
Journal:  Clin Exp Nephrol       Date:  2017-06-08       Impact factor: 2.801

7.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.

Authors:  Lene Ryom; Amanda Mocroft; Ole Kirk; Signe W Worm; David A Kamara; Peter Reiss; Michael Ross; Christoph A Fux; Philippe Morlat; Olivier Moranne; Colette Smith; Jens D Lundgren
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

Review 8.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

Review 10.  Atazanavir: its role in HIV treatment.

Authors:  Robin Wood
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.